Weightloss medication semaglutide (sold under trade names of Ozempic, Wegovy and Rybelsus) has been available by prescription since 2017. By 2022, it was the 48th most commonly prescribed drug. Since it came on the market, it is estimated that over 8,400,000 prescriptions have been issued for diabetes and weight management.

Your clients may not tell you, but some of them are using it. Be prepared to partner with them, supporting their health goals. Be ready to set aside judgement and meet them where they are with solid materia medica and dosing options for their challenges. Join Karen Allen for this special webinar, as she discusses common client experiences, side effects that can be managed with homeopathy, and successful transition with a taper off the medication for those who use it for weight loss.